ATE53569T1 - Benzylaminoxidaseinhibitoren, selektiv in beziehung auf andere aminoxidasen. - Google Patents

Benzylaminoxidaseinhibitoren, selektiv in beziehung auf andere aminoxidasen.

Info

Publication number
ATE53569T1
ATE53569T1 AT86830054T AT86830054T ATE53569T1 AT E53569 T1 ATE53569 T1 AT E53569T1 AT 86830054 T AT86830054 T AT 86830054T AT 86830054 T AT86830054 T AT 86830054T AT E53569 T1 ATE53569 T1 AT E53569T1
Authority
AT
Austria
Prior art keywords
sup
groups
inhibitors
benzylaminoxidase
aminoxidases
Prior art date
Application number
AT86830054T
Other languages
English (en)
Inventor
Vincenzo Bertini
Munno Angela De
Francesco Lucchesini
Franca Buffoni
Barbara Bertocci
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Application granted granted Critical
Publication of ATE53569T1 publication Critical patent/ATE53569T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT86830054T 1985-04-01 1986-03-10 Benzylaminoxidaseinhibitoren, selektiv in beziehung auf andere aminoxidasen. ATE53569T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT47906/85A IT1181871B (it) 1985-04-01 1985-04-01 Inibitori selettivi delle benzilamminossidasi rispetto ad altre amminossidasi
EP86830054A EP0210140B1 (de) 1985-04-01 1986-03-10 Benzylaminoxidaseinhibitoren, selektiv in Beziehung auf andere Aminoxidasen

Publications (1)

Publication Number Publication Date
ATE53569T1 true ATE53569T1 (de) 1990-06-15

Family

ID=11263264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86830054T ATE53569T1 (de) 1985-04-01 1986-03-10 Benzylaminoxidaseinhibitoren, selektiv in beziehung auf andere aminoxidasen.

Country Status (7)

Country Link
US (1) US4888283A (de)
EP (1) EP0210140B1 (de)
JP (1) JPS61239891A (de)
AT (1) ATE53569T1 (de)
CA (1) CA1303045C (de)
DE (2) DE210140T1 (de)
IT (1) IT1181871B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
JP2004536064A (ja) * 2001-01-23 2004-12-02 ピーアンドジー−クレイロール・インコーポレイテッド 酸化毛髪染色において使用する新規のカップラー
AR042941A1 (es) 2003-01-27 2005-07-06 Fujisawa Pharmaceutical Co Derivados de tiazol, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos inhibidores de la proteina-1 de adhesion vascular (vap-1)
US20060229346A1 (en) * 2003-03-31 2006-10-12 Sucampo Ag Method for treating vascular hyperpermeable disease
EP1786792B1 (de) * 2004-07-27 2009-04-08 Astellas Pharma Inc. Thiazolderivate mit vap-1-hemmender wirkung
CA2579889A1 (en) * 2004-09-09 2006-03-16 Astellas Pharma Inc. Thiazole derivatives having vap-1 inhibitory activity
TWI437986B (zh) 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為vap-1抑制劑之用途
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
TW201116276A (en) 2009-09-16 2011-05-16 Astellas Pharma Inc Glycine compounds
HUE034860T2 (en) 2011-03-15 2018-03-28 Astellas Pharma Inc Guanidin Compound
JP2018076236A (ja) 2015-06-05 2018-05-17 株式会社アールテック・ウエノ がんを処置するための医薬組成物
MX2020002441A (es) * 2017-09-05 2020-09-03 Mti Biotech Inc Composiciones y metodos de uso de depuradores de gammacetoaldehido para tratar, prevenir o mejorar fibrosis del higado.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1989093A (en) * 1929-05-02 1935-01-29 Sharp & Dohme Inc Amino alcohols and the production thereof
US2553441A (en) * 1947-03-29 1951-05-15 Universal Oil Prod Co Stabilization of organic materials
US3070628A (en) * 1959-08-04 1962-12-25 Upjohn Co 4-allyloxybenzylamines
US3320314A (en) * 1964-01-22 1967-05-16 Sandoz Ag Chlorobenzyl sulfamides
US3399226A (en) * 1965-10-22 1968-08-27 Merck & Co Inc Preparation of phenylalanine compounds
DE1543388B1 (de) * 1966-12-23 1970-10-01 Boehringer Mannheim Gmbh Basisch substituierte,tricyclische heterocyclische Verbindungen und deren pharmakologisch nicht giftige Salze sowie Verfahren zu ihrer Herstellung
US4073942A (en) * 1972-10-23 1978-02-14 Boehringer Ingelheim Gmbh Halo-substituted hydroxybenzyl-amines as secretolytic agents
US3951970A (en) * 1973-10-01 1976-04-20 Sharps Associates Resorcinol amine derivatives
US3960958A (en) * 1974-08-26 1976-06-01 Pfizer Inc. 3,4- AND 3,5-Dialkoxybenzylamines
US4014937A (en) * 1974-08-26 1977-03-29 Pfizer Inc. 3,4-And 3,5-dialkoxyphenethylamines
US4388250A (en) * 1982-03-15 1983-06-14 Rhone Poulenc Inc. Process for the preparation of p-hydroxy-benzyl-nitriles and corresponding amines

Also Published As

Publication number Publication date
EP0210140A2 (de) 1987-01-28
DE3671890D1 (de) 1990-07-19
EP0210140A3 (en) 1987-05-27
US4888283A (en) 1989-12-19
JPS61239891A (ja) 1986-10-25
IT1181871B (it) 1987-09-30
EP0210140B1 (de) 1990-06-13
IT8547906A0 (it) 1985-04-01
CA1303045C (en) 1992-06-09
DE210140T1 (de) 1987-07-23

Similar Documents

Publication Publication Date Title
ES8401959A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
SE8704599L (sv) Teobrominderivat
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
ATE53569T1 (de) Benzylaminoxidaseinhibitoren, selektiv in beziehung auf andere aminoxidasen.
BE848496A (fr) Derives d'amino-alcools, leur preparation et utilisation, ainsi que compositions contenant ces derives.
NZ216785A (en) 3-phenyl-3-(3-aminopropyl)-dihydrobenzofuran derivatives and pharmaceutical compositions
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
ATE173727T1 (de) Substituierte chinoline für die behandlung von leismaniosen
KR880009959A (ko) 방향족 아민 유도체
KR850005433A (ko) 나프티리딘 및 피리도피리미딘 화합물의 제조방법
ES8707226A1 (es) Procedimiento para preparar derivados de (dihidro-4, 5-1h-imidazolil-2)-2-didrido-2,3-indol
BE855163A (fr) Nouveaux 17 beta -esters de testosterone et de 5 alpha -dihydrotestoterone utiles comme androgenes a administration orale
ES445944A1 (es) Procedimiento de preparacion de derivados de 8-amino-teofi- lina.
KR830010090A (ko) 아닐린 유도체의 제조방법
ES480873A1 (es) Un procedimiento para la obtencion de triazolidin-3-onas o- tionas.
DK145286D0 (da) Bicyclooctanderivater
ATE63910T1 (de) Diphenyletherderivate.
JPS5239674A (en) Imidazole derivatives and agricultural bactericides therefrom
ES8500909A1 (es) Procedimiento para preparar derivados de bencimidazol
TH892EX (th) อนุพันธ์ไทรฟลูออโรมีเธนซัลโฟนานิลีดและการใช้ประโยชน์
KR860007876A (ko) 제초제 조성물
JPS5283672A (en) Novel 2-amino-1,4-dihydropyridine derivatives
JPS5371059A (en) Preparation of 1-substd.-3-amino-4-substd. thioazetidinone deriv. or theiracid salts
JPS5212168A (en) 6-amino chroman derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties